Core Scientific (CORZR) Free Cash Flow (2021 - 2026)

Core Scientific's Free Cash Flow history runs 6 years deep, the most recent figure standing at -$139.3 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 8.0% year-over-year to -$139.3 million; the TTM figure through Mar 2026 stood at -$461.1 million (down 126.93% YoY), while the FY2025 annual figure was -$450.8 million, down 765.74% from the prior year.
• Free Cash Flow came in at -$139.3 million for Q1 2026 at Core Scientific, down from -$121.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $178.3 million in Q4 2022 to a low of -$139.3 million in Q1 2026.
• A 5-year average of -$33.5 million and a median of -$26.1 million in 2022 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow surged 170.44% in 2023 and tumbled 7656.62% in 2025, its largest moves.
• Core Scientific's Free Cash Flow stood at $178.3 million in 2022, then tumbled by 94.36% to $10.1 million in 2023, then sank by 248.67% to -$15.0 million in 2024, then plunged by 714.14% to -$121.7 million in 2025, then fell by 14.47% to -$139.3 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$139.3 million, -$121.7 million, and -$112.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison